相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PSMB4 promotes multiple myeloma cell growth by activating NF-kappa B-miR-21 signaling
Peihao Zheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells
Johannes Kraus et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Bruton Tyrosine Kinase Is a Therapeutic Target in Stem-like Cells from Multiple Myeloma
Ye Yang et al.
CANCER RESEARCH (2015)
Ibrutinib inhibits BTK-driven NF-κB p65 activity to overcome bortezomib-resistance in multiple myeloma
Megan Y. Murray et al.
CELL CYCLE (2015)
Novel therapeutic strategies for multiple myeloma
Naoya Mimura et al.
EXPERIMENTAL HEMATOLOGY (2015)
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation
Vassilios Lougaris et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
MicroRNA-21 and multiple myeloma: small molecule and big function
Jing Ma et al.
MEDICAL ONCOLOGY (2014)
BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-kappa B
Stuart A. Rushworth et al.
CELLULAR SIGNALLING (2013)
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
Emanuela Leone et al.
CLINICAL CANCER RESEARCH (2013)
MicroRNA-21: a therapeutic target for reversing drug resistance in cancer
Liu Hong et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide
Meletios A. Dimopoulos et al.
BLOOD (2012)
Molecular Targets for the Treatment of Multiple Myeloma
Marco Rossi et al.
CURRENT CANCER DRUG TARGETS (2012)
Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma
P. Tassone et al.
CURRENT CANCER DRUG TARGETS (2012)
MicroRNAs, new effectors and regulators of NF-κB
Mark P. Boldin et al.
IMMUNOLOGICAL REVIEWS (2012)
被撤回的出版物: DNA Damage Induces NF-κB-dependent MicroRNA-21 Up-regulation and Promotes Breast Cancer Cell Invasion (Retracted article. See vol. 294, pg. 18015, 2019)
Jixiao Niu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identification of Novel miR-21 Target Proteins in Multiple Myeloma Cells by Quantitative Proteomics
Qian Xiong et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Pathogenesis of Myeloma
Kenneth C. Anderson et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Novel therapies in MM: from the aspect of preclinical studies
Teru Hideshima et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)
Ji-guang Zhang et al.
CLINICA CHIMICA ACTA (2010)
Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
Dennis Loeffler et al.
BLOOD (2007)
Nuclear factor-κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis
AC Bharti et al.
BLOOD (2004)
分享论文
